White label ELPA - ClinicalTrials.eu

Study on Tiotropium for Preventing Severe Asthma Attacks in Preschool Children with Uncontrolled Asthma

Not recruiting

3 1
Investigated Diseases:
- Asthma
Investigated Drugs:
- Tiotropium Bromide Monohydrate
Study on Long-Term Safety and Tolerability of Iptacopan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Not recruiting

3 1 1
Investigated Drugs:
- Iptacopan
+1
Study on the Safety and Effects of Volrustomig and Axitinib for Patients with Advanced Kidney Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Renal cell carcinoma
Investigated Drugs:
- Lenvatinib
- Volrustomig
Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated Drugs:
Study of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Small cell lung cancer extensive stage
Investigated Drugs:
+1
Study on Giredestrant and Everolimus for Patients with Estrogen Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Safety of DNL310 for Children with Hunter Syndrome

Not recruiting

2 1 1
Investigated Diseases:
- Mucopolysaccharidosis II
Investigated Drugs:
- Iduronate-2-Sulfatase Fused To A Fc Polypeptide That Binds To The Human Transferrin Receptor
Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
Study on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More

Not recruiting

3 1 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Brodalumab
+3
Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

Not recruiting

3 1 1
Investigated Drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies